文献速递细菌感染、耐药与抗菌药物艾滋病与性传播感染

新西兰淋病奈瑟菌基因组流行病学与抗菌药物耐药性研究

Genomic epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in New Zealand.
PubMed 文献 · J Antimicrob Chemother · 2018-01-01

该研究对新西兰2014年10月至2015年5月398株淋病奈瑟菌分离株进行药敏试验和全基因组测序,推断菌株亲缘关系并关联耐药突变与表型。共识别11个簇,耐药普遍;3.5%分离株对广谱头孢菌素MIC升高,10.8%对阿奇霉素非敏感。簇中女性比例较高提示传播不限于MSM,需重新评估传播风险因素并针对性干预。

要点

  • 98%分离株对青霉素非敏感,32%对环丙沙星非敏感,68%对四环素非敏感。
  • 3.5%分离株对广谱头孢菌素MIC升高,10.8%对阿奇霉素非敏感。
  • 簇中女性比例较高,提示传播不限于男男性行为人群。

核心结论

  • 新西兰淋病奈瑟菌耐药普遍,且广谱头孢菌素MIC升高与阿奇霉素非敏感在亲缘关系密切的菌株中被发现,亟需针对性公共卫生干预以阻断传播。
  • 簇中女性比例较高提示传播并非仅限于MSM,可能需重新评估传播风险因素。

研究设计与样本

  • 基于新西兰2014年10月至2015年5月398株淋病奈瑟菌分离株的人群水平研究,采用全面药敏试验和全基因组测序数据。
  • 通过系统发育树和成对核心SNP推断菌株亲缘关系,识别已知耐药相关突变和基因并与表型关联。

主要发现

  • 共识别11个簇,其中6个簇中超过25%的分离株来自女性,8个簇中超过15%的分离株来自女性。
  • 98%、32%和68%的分离株分别对青霉素、环丙沙星和四环素非敏感。
  • 3.5%的分离株广谱头孢菌素MIC升高(头孢克肟MIC≥0.12 mg/L,头孢曲松MIC≥0.06 mg/L)。
  • 仅9株分离株具有penA XXXIV基因型,其中3株对广谱头孢菌素敏感性降低(MIC=0.12 mg/L)。
  • 43株(10.8%)对阿奇霉素非敏感,其中2株具有23S突变(C2611T,4/4等位基因),所有菌株均有mtrR或其启动子突变。

临床怎么用

  • 在新西兰背景下应重新评估淋病传播风险因素,关注女性人群中的传播。
  • 对广谱头孢菌素MIC升高和阿奇霉素非敏感的密切 related 菌株需采取针对性公共卫生干预以阻断传播。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antimicrobial-resistant Neisseria gonorrhoeae is a major threat to public health. No studies to date have examined the genomic epidemiology of gonorrhoea in the Western Pacific Region, where the incidence of gonorrhoea is particularly high. METHODS: A population-level study of N. gonorrhoeae in New Zealand (October 2014 to May 2015). Comprehensive susceptibility testing and WGS data were obtained for 398 isolates. Relatedness was inferred using phylogenetic trees, and pairwise core SNPs. Mutations and genes known to be associated with resistance were identified, and correlated with phenotype. RESULTS: Eleven clusters were identified. In six of these clusters, >25% of isolates were from females, while in eight of them, >15% of isolates were from females. Drug resistance was common; 98%, 32% and 68% of isolates were non-susceptible to penicillin, ciprofloxacin and tetracycline, respectively. Elevated MICs to extended-spectrum cephalosporins (ESCs) were observed in 3.5% of isolates (cefixime MICs ≥ 0.12 mg/L, ceftriaxone MICs ≥ 0.06 mg/L). Only nine isolates had penA XXXIV genotypes, three of which had decreased susceptibility to ESCs (MIC = 0.12 mg/L). Azithromycin non-susceptibility was identified in 43 isolates (10.8%); two of these isolates had 23S mutations (C2611T, 4/4 alleles), while all had mutations in mtrR or its promoter. CONCLUSIONS: The high proportion of females in clusters suggests transmission is not exclusively among MSM in New Zealand; re-assessment of risk factors for transmission may be warranted in this context. As elevated MICs of ESCs and/or azithromycin were found in closely related strains, targeted public health interventions to halt transmission are urgently needed.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Lee RS, Seemann T, Heffernan H, et al. Genomic epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in New Zealand. J Antimicrob Chemother. 2018. PMID: 29182725. doi:10.1093/jac/dkx405

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。